title: [Optimum mode of interventional treatment for hepatocellular carcinoma].
abstract: OBJECTIVE
  To establish a reasonable protocol for interventional treatment of hepatocellular carcinoma (HCC).
  
  
  METHODS
  The data of 1 000 HCC patients treated by different kinds of interventional treatment were reviewed with their results of biochemistry, imaging, pathology and survival rate evaluated. The value as well as the pros and cons of these various kinds of interventional treatment were compared in order to find an optimum protocol.
  
  
  RESULTS
  Segmental-transcatheter oil chemoembolization (S-TOCE) was much effective eradicate the tumor yet inflicting less damage on the noncancerous hepatic tissue and giving much higher survival rate than the conventional transcatheter oil chemoembolization (C-TOCE). Percutaneous ethanol injection (PEI) played an important role in eradicating the residual tumor and improving the survival rate without damaging the noncancerous hepatic tissue. The survival quality or survival rate could be improved by choosing different ways of interventional treatments to cut down the complications.
  
  
  CONCLUSIONS
  The selection of different interventional treatments should be done according to the size and type of HCC. Active management is indicated for different complications presenting along with HCC.
authors.affiliation: Department of Oncology, Guangdong Provincial People's Hospital, Guangzhou 510080, China.
authors.forename: Xiaoming
authors.initials: X
authors.lastname: Chen
authors.forename: Pengfei
authors.initials: P
authors.lastname: Luo
authors.forename: Huahuan
authors.initials: H
authors.lastname: Lin
authors.forename: Peijian
authors.initials: P
authors.lastname: Shao
authors.forename: Zejian
authors.initials: Z
authors.lastname: Zhou
authors.forename: Li
authors.initials: L
authors.lastname: Fu
mesh_terms: D006528:Carcinoma, Hepatocellular / Q000401:mortality / Q000628:therapy*; D016461:Chemoembolization, Therapeutic; D006801:Humans; D008113:Liver Neoplasms / Q000401:mortality / Q000628:therapy*; D012189:Retrospective Studies; D015996:Survival Rate